Gross Margin

With strong HIFU revenue and new clinical trials, EDAP TMS's upcoming Investor Day will reveal its strategy for medtech dominance and investor confidence.

As the space economy booms, a top TMT research firm launches dedicated coverage, signaling a new era of financial scrutiny for giants like SpaceX and Rocket Lab.

A new six-month semaglutide implant is entering clinical trials, aiming to solve the adherence crisis plaguing GLP-1 drugs like Ozempic and Wegovy.

AutoCanada posts a Q1 loss amid a soft market, accelerating its U.S. dealership sale and relying on new leadership and its collision arm for recovery.

How a 125-year-old family flour mill earned Gold Honoree status by blending heritage with high-tech innovation and sustainable food solutions.

A new report reveals a record 4,434 satellites launched in 2025, as the industry's revenue soars and U.S. innovation solidifies its global dominance.

Sony unleashes the FE 100-400mm F4.5 GM OSS, a pricey super-telephoto with a constant aperture and blazing AF aimed at pro sports and wildlife shooters.

The luggage giant reports a 4.1% revenue increase and a major cash flow turnaround, while advancing plans for a strategic US stock market debut this year.

A $25M payment from partner Chiesi catapults Protalix to a profitable quarter, funding a promising new gout therapy and a broader rare disease strategy.

As Quebecor prepares for its annual meeting, a look at its strong 2025 results, aggressive telecom expansion, and strategy to challenge Canada's giants.

The nation's largest EMS provider, GMR Solutions, saw its stock surge on its NYSE debut after a major IPO price cut to appease wary investors.

JBS posts a $221M profit despite a major loss in its US beef unit, showcasing the power of its diversified global strategy in volatile markets.

The industrial giant affirms its quarterly payout, a sign of stability for investors as it navigates a costly green transition and recent regulatory hurdles.

As BranchOut Food preps its Q1 earnings call, investors watch to see if its patented tech and retail wins can deliver on the path to profitability.

The cell-engineering firm posted a smaller-than-expected loss and announced a share buyback, signaling confidence despite a dip in core Q1 revenue.

Resideo posted strong Q1 results with an 8% revenue jump to $1.91B, setting a positive stage for the planned separation of its ADI distribution arm.

Amid a surging lithium market, Lithium Argentina posts stellar Q1 results, using its operational prowess to fund ambitious expansion projects in Argentina.

The medtech firm reports a 19% revenue surge and a return to profitability, validating its new pure-play strategy focused on the surgical market.

A massive acquisition and a surge in urea prices propelled Adecoagro to a record quarter, offsetting commodity slumps and redefining its future.

Backed by Dongfeng and already profitable, Chinese EV brand VOYAH is charting a unique global path with production-ready tech and a disciplined strategy.